$QNTA Medolife Rx Schedules Conference Call with Investment Community To Discuss Third Quarter 2021 Financial and Operational Results and New Updates
Medolife Rx, Inc. ("Medolife" , a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that it has scheduled a conference call with investors for Tuesday, November 23rd.

Conference Call Topics:

Bi-annual visit and filing with Ministry of Environment;

Tony Hawk ad campaign;

257% increase in efficacy of Ibuprofen using proprietary polarization technique from internal study;

Update on comparative study on CBD muscle rub, which showed a significant efficacy increase caused by polarization technology;

Update on progress with the government of the Dominican Republic;

Update on FINRA on the name and symbol change;

Update on the AELIA comparative study;

Update on Mexico distribution;

Update on social media sales programs;

Update on big box retailer conversations;

New business verticals, such as polarized ribosomes.

https://finance.yahoo.com/news/medolife-rx-sc...00507.html